Paying for cost-effective health care: Does it violate both static- and dynamic efficiency?

Abstract

Recent research has questioned the rationales of using cost-effectiveness metrics of medical technologies to guide reimbursement. I discuss here the underlying ideas of this research, which argues that reimbursement based on cost effectiveness criteria leads to both static- and dynamic inefficiencies.

Keywords

• pharmaceuticals
• reimbursement
• cost-effectiveness analysis